Global Blood Therapeutics CMO Eleanor Ramos retires
Dr. Ramos, an industry veteran with with more than 20 years of experience in the biotechnology and pharmaceutical industries, oversees Global Blood Therapeutics' clinical development and medical affairs.
Prior to joining Global Blood Therapeutics, Dr. Ramos served as chief medical officer of Theraclone Sciences where she led the development of monoclonal antibody therapies for viral diseases.
Prior to Theraclone, she held the role of senior vice president and chief medical officer at ZymoGenetics.
Dr. Ramos also led significant clinical research and development initiatives while at Bristol-Myers Squibb and Roche Global Development. She held faculty appointments at Harvard Medical School, the University of Florida, Yale University and the University of California, San Francisco.
Dr. Ramos began her medical career as an academic transplant nephrologist following completion of medical and subspecialty training at Tufts University and Brigham & Women's Hospital.
Dr. Ramos holds an M.D. from Tufts University School of Medicine and completed her training in transplant nephrology at the Brigham and Women's Hospital. ■
LATEST MOVES FROM California
- PennyMac Financial Services appoints Theodore W. Tozer to board
- Apple appoints Isabel Ge Mahe managing director of Greater China
- Seagate Technology appoints Ravi Naik as CIO
- MannKind appoints Steven Binder as CFO
- Achaogen appoints Karen Bernstein to board
More inside POST
Suppliers will pay fine to Wal-Mart if they are late. Or early. Or not packed properly. Or... Companies